Kyrgyzstan InterSectional Stigma Injection Drug Use Cohort (KISS)
The KISS study aims to investigate the overlapping experiences of drug use, methadone maintenance treatment (MMT) and Human immunodeficiency virus (HIV) stigma amongst rural and urban people who inject drugs (PWID) in Kyrgyzstan. The study recruited participants from Bishkek and the surrounding province of Chuy Oblast in northern Kyrgyzstan. Eligible participants were at least 18 years old, had injected drugs within 30 days before recruitment, resided in the study area with no plans to move within 12 months, and agreed to an HIV test. The baseline cohort consisted of over 270 participants from both rural and urban locales.
Study design
Cohort
Number of participants at first data collection
279 (participants)
Age at first data collection
35 - 46 years (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Country
Year of first data collection
2021
Primary Institutions
AIDS Foundation – East West (now known as AFEW International)
Johns Hopkins University (JHU)
St. Michael’s Hospital
University of California, San Diego (UC San Diego)
Links
No website available
Profile paper DOI
Funders
Canadian Institutes of Health Research (CIHR, Instituts de recherche en santé du Canada, IRSC)
National Institutes of Health (NIH)
Ongoing?
Yes
Data types collected
- Interview – face-to-face
- Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
- None
- None
- None
Engagement
Keywords
